Pharmaceutical intermediates
Sotorasib Intermediates
11 pharmaceutical intermediates for Sotorasib. Indication: Colorectal Cancer; Non-Small Cell Lung Cancer.
About Sotorasib
- Originator
- Amgen Inc
- Indication
- Colorectal Cancer; Non-Small Cell Lung Cancer
- Approved Date
- 01/20/2023
- NCE Patent
- 05/28/2026
- DS/DP
- 05/21/2038
Available intermediates
11 intermediates currently listed for Sotorasib. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione | 2252403-82-8 | / | / |
| tert-butyl (S)-4-(7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate | 2252403-84-0 | / | / |
| 4-[(S)-4-Boc-2-methyl-1-piperazinyl]-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methyl-3-pyridyl)pyrido[2,3-d]pyrimidin-2(1H)-one | 2252403-85-1 | / | / |
| Potassium Trifluoro(2-fluoro-6-hydroxyphenyl)borate | 2252415-10-2 | / | / |
| 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione | 2300966-23-6 | / | / |
| 2,6-Dichloro-5-fluoronicotinamide | 113237-20-0 | / | / |
| isopropyl-4-methylpyridin-3-amine | 1698293-93-4 | / | / |
| Fluoro-6-hydroxyphenylboronic acid | 1256345-60-4 | / | / |
| (S)-4-N-Boc-2-methylpiperazine | 147081-29-6 | / | / |
| 2-Fluoro-6-methoxyphenylboronic acid | 78495-63-3 | / | / |
| 2-Fluoro-6-hydroxybenzeneboronic acid pinacol ester | 1534369-41-9 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →